Group items matching

in title, tags, annotations or url

Dr Bharat Shah CBE regrets that neither community pharmacists nor pharmaceutical wholesalers in the UK have any control over how Category m reimbursement prices in Part VIII A of the Drug Tariff are determined. The co-founder and chief executive of Sigma Pharmaceuticals was speaking at a conference organised by Avicenna in West London on Sunday (march 6). Introduced into the Drug Tariff in April 2005, Category m is used to set the reimbursement prices of over 500 drugs. The Department of Health and Social Care makes the final decision on the amount of reimbursement (cost of drugs and appliances supplied against an NHS prescription form) and remuneration (fees paid as part of the NHS community pharmacy contract for the provision of a service).

The Hyderabad Police are actively searching for UK-based pharmacist m. Ajith Kumar, who is suspected of involvement in a plot to poison his estranged wife's family in Hyderabad by contaminating their spices with arsenic. While the accused allegedly succeeded in fatally poisoning his mother-in-law through a slow method, timely arsenic testing saved the lives of others. In late June, a newlywed woman in her 30s visited a Guntur-based doctor, complaining of intense burning, tingling, and numbness in her hands and feet. The neurologist's keen observation foiled the alleged sinister plot of Ajith Kumar, suspected of using his chemical expertise to harm his wife and her family. Presently, the police are actively searching for m. Ajith Kumar, who is currently in London, in connection with the murder plot. Furthermore, the Hyderabad police have apprehended six individuals from the city who were complicit in his nefarious scheme. The investigation gathered key information from arrested suspects, including D. Vinod Kumar, a UK-based IT professional from Andhra Pradesh. Vinod Kumar's involvement in UK software projects provided by Ajith Kumar generated a substantial monthly income, leading him to assist Ajith in his plot against his estranged wife's family.

The NHS Business Services Authority (NHSBSA) has published the Drug Tariff Category M price list for July which reflects an increase in reiMburseMent level of approxiMately £5M per quarter. An adjustMent of -£23.8M was announced, in light of the results of the Margin survey (latest result up until end of DeceMber 2022), and the phasing down of the additional £100M agreed across years 4 and 5 as part of the CoMMunity PharMacy Contractual FraMework and uplifts for underlying Market prices (between January - March 2023). CoMMunity PharMacy England has agreed the adjustMents based on the analysis of Margin delivery and on current projections for 2023/24. It said: "The objectives are to ensure full delivery of agreed Margin and sMooth delivery as Much as possible. As always, the iMpact on individual pharMacies will vary depending on dispensing Mix."

There is a realistic possibility of large waves of Covid-19 infection in the future in Britain and such waves might even be considered likely, epidemiologists who model the Covid-19 pandemic to inform government advice have said. Prime minister Boris Johnson has ditched legal restrictions in England, saying that, while the pandemic was not over, Britain needs to learn to live with Covid. The Scientific Pandemic Influenza Group on modelling, Operational sub-group (SPI-m-O) said the emergence of new viral variants was the biggest unknown factor in the medium-to-long term, along with waning population immunity and changes in mixing patterns. "Large future waves of infection that need active management to prevent detrimental pressure on the health and care sector are, at least, a realistic possibility (high confidence) or likely (medium confidence)," SPI-m-O said in a consensus statement published on Friday.

Archie Norman, the chairman of marks & Spencer said that shoplifting is "creeping in" among the middle class because of faulty self-checkouts. He said that the surge is due to the well-off shoppers being "tempted" to walk out without paying for their items when self-checkouts failed to register their items properly. The m&S chairman told LBC's podcast money with David Buik and michael Wilson that shoplifting has become a "global problem". "It's too easy to say it's a cost of living problem. Some of this shoplifting is gangs. Then you get the middle class," mr Norman said.

Dr. M. I. Sahadulla is the Group ChairMan & Managing Director, of KIMS Healthcare Group. If there is one word that captures Dr. Sahadulla's approach to life and work, it is passion.

Backed by a £22.5 million of government funding, community vaccine champions will tap into their local networks and encourage people in their communities to get vaccinated against the Covid-19. The funding, allocated today (January 13) to 60 councils, will help deliver bespoke projects in these regions, including: In Derby and Newham roving vaccinators and a vaccine bus will visit workplaces, places of worship and local highstreets.Videos shared on social media featuring local sporting stars, TV actors, local community and faith leaders and local NHS staff in Southampton.Developing a community transport to support access to vaccination sites/pop-ups and considering 'Grab a Jab' taxis scheme.As per NHS statistics, over 4.6 million people aged 18 and above remained unvaccinated in the 60 councils, selected to be a part of the Community Vaccine Champions programme. Vaccines minister maggie Throup said: "Thanks to the pace and scale of our Covid-19 vaccination programme, we are in a much better position than this time last year."

The Department of Health and Social Care's (DHSC) response to the 2019 consultation on community pharmacy drug reimbursement reform has paved the way for the second phase of consultation with the pharmacy negotiator. The second round of the consultation will focus on eight proposals: Changes to the way Category A prices are set Changes to how medicine margin is distributed in Category m drugs Changes to how Category C prices are set for drugs with multiple suppliers Inclusion of non-medicinal products in the Drug Tariff Changes to the way prices of drugs in non-Part VIIIA are set Changes to arrangements for reimbursement and procurement of 'specials' Changes to reimbursement of generically prescribed drugs and appliances dispensed as 'specials' Changes to the discount deduction scale The Pharmaceutical Services Negotiating Committee has been discussing these proposals with the DHSC and the outcome was featured in the final package of the 'Community pharmacy in 2016/17 and beyond' document.

Any prescription for Promethazine hydrochloride 10mg tablets x 56 submitted for payment to the NHSBSA for July 2022 will be reimbursed at the new price of £17.77 not as per the price concession of £13.45 announced in the 4th concessions update published on 29 July 2022, said the Pharmaceutical Services Negotiating Committee (PSNC). In July 2022, PSNC received several reports from contractors unable to obtain Promethazine hydrochloride 10mg tablets (56) at the published Drug Tariff price of £4.24. Therefore, it submitted a request for a price concession, which was granted and subsequently published but this was later withdrawn after confirmation from the Department of Health and Social Care (DHSC) that due to the price change mechanism, the reimbursement price for Promethazine hydrochloride 10mg tablets has increased from £4.24 to £17.77 for July 2022. PSNC said, "Following the price change mechanism rules, for generic drugs (excluding drugs in Category m), a price change up to and including the 8th of the month takes effect for prescriptions dispensed in that same month. Any price change after the 8th takes place in the following month."

An Indian court has sentenced two pharmaceutical company executives to two-and-half years in jail for exporting substandard drugs to Vietnam a decade ago, months after the WHO linked their cough syrups to the deaths of children in Gambia. India suspended production at maiden Pharmaceuticals in October last year for violations of manufacturing standards after the World Health Organization said four of its cough syrups may have killed dozens of children in Gambia. The company has denied its drugs were at fault for the deaths in Gambia and tests by an Indian government laboratory found there were no toxins in them. The company had been facing legal difficulties for years over suspected shoddy products. A court in Sonipat, near New Delhi, where maiden has its main production facility, ordered jail for company founder Naresh Kumar Goel and technical director m.K. Sharma for exporting heartburn medicine "not of standard quality" to Vietnam.

The General Pharmaceutical Council (GPhC) has announced the names of five new members who will be joining its governing Council over the next two years. The new council members are: Professor Dianne Ford, Pro Vice-Chancellor of the Faculty of Health and Life Sciences at Northumbria University. Gareth Powell, a chartered accountant and a Non-Executive Director on the Board of the Port of milford Haven, the UK's largest energy port. Adeyemi (Ade) Williams mBE, Superintendent Pharmacist and Director of the m J Williams Pharmacy and lead Pharmacist at the Bedminster Pharmacy, Bristol. Tim Jaggard, Deputy Chief Executive and Chief Financial Officer at University College London Hospitals NHS Foundation Trust. Dr Raliat Onatade, Chief Pharmacist and Director of medicines and Pharmacy for North-East London Integrated Care System. Professor Ford, Powell and Williams will begin their terms on 1 April 2024, replacing Jo Kember, mark Hammond and Arun midha.

People will also be surrounded by summer skin problems and many other health related problems. In the summer, people like to eat more liquid things than eating-like juice, honey or coconut water.

Under the current circumstance, when New Yorkers are looking in the eye of COVID-19, to say that it brings the best out of them will not be wrong.

The Pharmaceutical Services Negotiating Committee (PSNC) has announced the margin delivery rates will increase from October as the agreed £100m write off is implemented. "The baseline margin allowance will remain £800m per year in 2022/23 and 2023/24," said PSNC. "margin levels in the last two full years (2020/21 and 2021/22), as measured by the margin Survey of independent pharmacies, were in excess of the baseline allowance, meaning that an excess was accrued." As new services have been introduced and take up of these has accelerated, the amount of unallocated funding left in the CPCF is now less than it previously was. As such, the value of the Transitional Payments will decrease from its current level. Some of the unallocated funding remaining in 2023/24 will be repurposed into a Flat Payment for all contractors (see details below). Over the course of the second half of 2022/23, the value of the Transitional Payments will be phased down. This will start in October 2022 with a reduction in payment levels to approximately 85% of the current level, as shown in the following table:

As an unprecedented demand for Lateral Flow Device (LFD) test kits continues through the Pharmacy Collect service, the UK Health Security Agency (UKHSA) is planning to distribute 10.5 million tests per week via Alliance Healthcare this month. By the end of this week (January 8), the UKHSA aims to distribute more than 8 million tests to Alliance Healthcare - sole distributor to pharmacies. The announcement comes after many in the pharmacy sector voiced concerns over shortage of test kits. Earlier this week, it emerged that Alliance Healthcare closed for four days shortly after receiving around 2.5 million tests on Christmas Eve. meanwhile, the UKHSA indicated that Alliance Healthcare has been delivering 86 per cent of its orders within 24 hours of the pharmacy order, nearly half of that on the same day. Besides, a plan to switch on a Parcel Force delivery contingency is being finalised by UKHSA, which would enable supply of a further 3.5 million test kits.